SPONSOR
Shanghai Yizhong Pharmaceutical Co., Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Pancreatic Cancer Metastatic
Shanghai Yizhong Pharmaceutical Co., Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Pancreatic Cancer Metastatic.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Yizhong Pharmaceutical Co., Ltd.
How many clinical trials has Shanghai Yizhong Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Shanghai Yizhong Pharmaceutical Co., Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Pancreatic Cancer Metastatic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Yizhong Pharmaceutical Co., Ltd. research focus on?
Shanghai Yizhong Pharmaceutical Co., Ltd. clinical trials span Pancreatic Cancer Metastatic. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Yizhong Pharmaceutical Co., Ltd. clinical trial?
To participate in a Shanghai Yizhong Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Yizhong Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shanghai Yizhong Pharmaceutical Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology